Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

June 01, 2004; Volume 32,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Anderton, Mark J.

    1. You have access
      PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
  2. Anzenbacher, Pavel

    1. You have access
      DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
  3. Arimori, Kazuhiko

    1. You have access
      POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

B

  1. Baillie, Thomas A.

    1. You have access
      VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
  2. Black, Virginia H.

    1. You have access
      MOLECULAR CLONING OF THE GUINEA PIG CYP1A2 GENE 5′-FLANKING REGION: IDENTIFICATION OF FUNCTIONAL AROMATIC HYDROCARBON RESPONSE ELEMENT AND CHARACTERIZATION OF CYP1A2 EXPRESSION IN GPC16 CELLS
      Virginia H. Black and Linda C. Quattrochi
      Drug Metabolism and Disposition June 2004, 32 (6) 595-602; DOI: https://doi.org/10.1124/dmd.32.6.595
  3. Borlak, Jürgen

    1. You have access
      ANDROGEN METABOLISM IN THYMUS OF FETAL AND ADULT RATS
      Jürgen Borlak, Ingo Schulte and Thomas Thum
      Drug Metabolism and Disposition June 2004, 32 (6) 675-679; DOI: https://doi.org/10.1124/dmd.32.6.675
  4. Bridges, Alexander J.

    1. You have access
      METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
  5. Buist, Susan C. N.

    1. You have access
      RAT AND MOUSE DIFFERENCES IN GENDER-PREDOMINANT EXPRESSION OF ORGANIC ANION TRANSPORTER (OAT1–3; SLC22A6–8) mRNA LEVELS
      Susan C. N. Buist and Curtis D. Klaassen
      Drug Metabolism and Disposition June 2004, 32 (6) 620-625; DOI: https://doi.org/10.1124/dmd.32.6.620

C

  1. Cai, Xiaoxin

    1. You have access
      VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

D

  1. Dean, Dennis C.

    1. You have access
      VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

E

  1. Edom, Richard W.

    1. You have access
      VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
  2. Evans, David C.

    1. You have access
      VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

F

  1. Frandsen, H.

    1. You have access
      IDENTIFICATION OF METABOLITES IN URINE AND FECES FROM RATS DOSED WITH THE HETEROCYCLIC AMINE, 2-AMINO-3-METHYL-9H-PYRIDO[2,3-b]INDOLE (MeAαC)
      H. Frederiksen and H. Frandsen
      Drug Metabolism and Disposition June 2004, 32 (6) 661-665; DOI: https://doi.org/10.1124/dmd.32.6.661
  2. Frederiksen, H.

    1. You have access
      IDENTIFICATION OF METABOLITES IN URINE AND FECES FROM RATS DOSED WITH THE HETEROCYCLIC AMINE, 2-AMINO-3-METHYL-9H-PYRIDO[2,3-b]INDOLE (MeAαC)
      H. Frederiksen and H. Frandsen
      Drug Metabolism and Disposition June 2004, 32 (6) 661-665; DOI: https://doi.org/10.1124/dmd.32.6.661
  3. Fujita, Ken-ichi

    1. You have access
      POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

G

  1. Gescher, Andreas

    1. You have access
      PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
  2. Goosen, Theunis C.

    1. You have access
      SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
      Chitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587
  3. Guengerich, F. Peter

    1. You have access
      DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
  4. Gut, Ivan

    1. You have access
      DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666

H

  1. He, Kan

    1. You have access
      METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
  2. Hidaka, Muneaki

    1. You have access
      POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581
  3. Hollenberg, Paul F.

    1. You have access
      SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
      Chitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587

I

  1. Iwakiri, Tomomi

    1. You have access
      POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

J

  1. Juntunen, Tarja

    1. You have access
      SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626

K

  1. Kent, Ute M.

    1. You have access
      SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
      Chitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587
  2. Klaassen, Curtis D.

    1. You have access
      RAT AND MOUSE DIFFERENCES IN GENDER-PREDOMINANT EXPRESSION OF ORGANIC ANION TRANSPORTER (OAT1–3; SLC22A6–8) mRNA LEVELS
      Susan C. N. Buist and Curtis D. Klaassen
      Drug Metabolism and Disposition June 2004, 32 (6) 620-625; DOI: https://doi.org/10.1124/dmd.32.6.620
  3. Kodama, Hirofumi

    1. You have access
      POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

L

  1. Liu, Wensheng

    1. You have access
      VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

M

  1. Mager, Donald E.

    1. You have access
      PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
  2. Manson, Margaret M.

    1. You have access
      PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632

N

  1. Nieminen, Riina

    1. You have access
      SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626

O

  1. Obach, R. Scott

    1. You have access
      VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES
      Robert L. Walsky and R. Scott Obach
      Drug Metabolism and Disposition June 2004, 32 (6) 647-660; DOI: https://doi.org/10.1124/dmd.32.6.647
  2. Ogikubo, Tetsuya

    1. You have access
      POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581
  3. Okumura, Manabu

    1. You have access
      POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

P

  1. Pelkonen, Olavi

    1. You have access
      SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626
  2. Pool, William F.

    1. You have access
      METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639

Q

  1. Quattrochi, Linda C.

    1. You have access
      MOLECULAR CLONING OF THE GUINEA PIG CYP1A2 GENE 5′-FLANKING REGION: IDENTIFICATION OF FUNCTIONAL AROMATIC HYDROCARBON RESPONSE ELEMENT AND CHARACTERIZATION OF CYP1A2 EXPRESSION IN GPC16 CELLS
      Virginia H. Black and Linda C. Quattrochi
      Drug Metabolism and Disposition June 2004, 32 (6) 595-602; DOI: https://doi.org/10.1124/dmd.32.6.595

R

  1. Raunio, Hannu

    1. You have access
      SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626
  2. Reed, Jessica E.

    1. You have access
      METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
  3. Reily, Michael D.

    1. You have access
      METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
  4. Rodrigues, A. David

    1. You have access
      VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

S

  1. Schulte, Ingo

    1. You have access
      ANDROGEN METABOLISM IN THYMUS OF FETAL AND ADULT RATS
      Jürgen Borlak, Ingo Schulte and Thomas Thum
      Drug Metabolism and Disposition June 2004, 32 (6) 675-679; DOI: https://doi.org/10.1124/dmd.32.6.675
  2. Shou, Magang

    1. You have access
      VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
  3. Simek, Petr

    1. You have access
      DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
  4. Smith, Brian R.

    1. You have access
      A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. I. CLEARANCE
      Keith W. Ward and Brian R. Smith
      Drug Metabolism and Disposition June 2004, 32 (6) 603-611; DOI: https://doi.org/10.1124/dmd.32.6.603
    2. You have access
      A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. II. VOLUME OF DISTRIBUTION AND MEAN RESIDENCE TIME
      Keith W. Ward and Brian R. Smith
      Drug Metabolism and Disposition June 2004, 32 (6) 612-619; DOI: https://doi.org/10.1124/dmd.32.6.612
  5. Soucek, Pavel

    1. You have access
      DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
  6. Sridar, Chitra

    1. You have access
      SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
      Chitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587
  7. Steward, William P.

    1. You have access
      PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
  8. Svobodova, Lenka

    1. You have access
      DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666

T

  1. Taavitsainen, Päivi

    1. You have access
      SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626
  2. Talaat, Rasmy E.

    1. You have access
      METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639
  3. Thum, Thomas

    1. You have access
      ANDROGEN METABOLISM IN THYMUS OF FETAL AND ADULT RATS
      Jürgen Borlak, Ingo Schulte and Thomas Thum
      Drug Metabolism and Disposition June 2004, 32 (6) 675-679; DOI: https://doi.org/10.1124/dmd.32.6.675
  4. Turpeinen, Miia

    1. You have access
      SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626

V

  1. Vaclavikova, Radka

    1. You have access
      DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666
  2. Verschoyle, Richard

    1. You have access
      PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632

W

  1. Walsky, Robert L.

    1. You have access
      VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES
      Robert L. Walsky and R. Scott Obach
      Drug Metabolism and Disposition June 2004, 32 (6) 647-660; DOI: https://doi.org/10.1124/dmd.32.6.647
  2. Wang, Regina W.

    1. You have access
      VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584
  3. Ward, Keith W.

    1. You have access
      A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. I. CLEARANCE
      Keith W. Ward and Brian R. Smith
      Drug Metabolism and Disposition June 2004, 32 (6) 603-611; DOI: https://doi.org/10.1124/dmd.32.6.603
    2. You have access
      A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. II. VOLUME OF DISTRIBUTION AND MEAN RESIDENCE TIME
      Keith W. Ward and Brian R. Smith
      Drug Metabolism and Disposition June 2004, 32 (6) 612-619; DOI: https://doi.org/10.1124/dmd.32.6.612
  4. Williams, J. Andrew

    1. You have access
      SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
      Chitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587
  5. Williams, Marion L.

    1. You have access
      PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632
  6. Woolf, Thomas F.

    1. You have access
      METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639

Y

  1. Yamasaki, Keishi

    1. You have access
      POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 32 (6)
Drug Metabolism and Disposition
Vol. 32, Issue 6
1 Jun 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Read
Loading
  • Bile Acids in Germ-Free Mice
  • Physiology of the Neonatal Gastrointestinal System
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • Pharmacokinetics and Disposition of Biologics
  • Metabolism and Disposition of Volanesorsen across Species
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics